<scp>KIFC1</scp> is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma
KIFC1 serves as a multifunctional molecule linking epithelial-mesenchymal transition, immune modulation, and treatment resistance. It may be a promising prognostic biomarker and therapeutic target in ccRCC, warranting further functional and clinical investigation.
Authors
- Kenshiro Takemoto (ORCID: https://orcid.org/0000-0002-9077-4733)
- Miki Naito (ORCID: https://orcid.org/0000-0003-3485-0751)
- Hikaru Nakahara (ORCID: https://orcid.org/0000-0003-2540-707X)
- Takao Hinoi
- Yoshinori Nakano
- Keisuke Hieda (ORCID: https://orcid.org/0000-0001-5182-8666)
- Shintaro Akabane (ORCID: https://orcid.org/0000-0002-6881-4305)
- Go Kobayashi
- AKIHIRO GORIKI
- Nobuyuki Hinata
- Hiroyuki Kitano
- YOHEI SEKINO
- Shunsuke Miyamoto
- Keisuke Goto
- Kohei Kobatake
Institutions
- Hiroshima University (JP)
- Radiation Effects Research Foundation (JP)
- Hiroshima University Hospital (JP)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1002/cam4.71687
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science